Literature DB >> 16827710

Chromosomal variation and genome size support existence of cryptic species of Triatoma dimidiata with different epidemiological importance as Chagas disease vectors.

F Panzera1, I Ferrandis, J Ramsey, R Ordòñez, P M Salazar-Schettino, M Cabrera, M C Monroy, M D Bargues, S Mas-Coma, J E O'Connor, V M Angulo, N Jaramillo, C Cordón-Rosales, D Gómez, R Pérez.   

Abstract

The wide geographical distribution of Triatoma dimidiata, one of the three major vectors of Chagas disease, ranges from Mexico to northern Peru. Since this species occupies a great diversity of artificial and natural ecotopes, its eradication is extremely difficult. In order to assist control efforts, we used chromosome analyses and DNA amount as taxonomic markers to study genetic variability in populations of T. dimidiata from Mexico, Guatemala, El Salvador and Colombia. We differentiated three groups or cytotypes defined by characteristic chromosome C-banding patterns and genome size measured by flow cytometry. The three cytotypes are restricted to different geographic locations. Cytotype 1 occurs in Mexico (excluding Yucatán), Guatemala (excluding Petén), El Salvador and Colombia. Cytotype 2 occurs in Yucatán and cytotype 3 occurs in Petén. Cytotype 1, commonly associated with domestic and peridomestic environments but also inhabiting sylvatic ecotopes, is the most widespread and with major epidemiological significance. In contrast, the Yucatán cytotype inhabits wild ecotopes but increasingly enters houses, while the Petén cytotype appears exclusively sylvatic. We suggest that these cytotypes represent cryptic species of T. dimidiata with different epidemiological relevance as Chagas disease vectors. Poor ability to colonize human dwellings, together with their restricted geographic distribution, indicate that the Yucatán and Petén putative species probably have much less epidemiological significance than cytotype 1. Thus, the genetic markers we describe are powerful tools to differentiate cryptic species in T. dimidiata with different epidemiological significance, contributing to planning the most effective control measures.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16827710     DOI: 10.1111/j.1365-3156.2006.01656.x

Source DB:  PubMed          Journal:  Trop Med Int Health        ISSN: 1360-2276            Impact factor:   2.622


  22 in total

1.  Hypothesis testing clarifies the systematics of the main Central American Chagas disease vector, Triatoma dimidiata (Latreille, 1811), across its geographic range.

Authors:  Patricia L Dorn; Nicholas M de la Rúa; Heather Axen; Nicholas Smith; Bethany R Richards; Jirias Charabati; Julianne Suarez; Adrienne Woods; Rafaela Pessoa; Carlota Monroy; C William Kilpatrick; Lori Stevens
Journal:  Infect Genet Evol       Date:  2016-08-02       Impact factor: 3.342

2.  High frequency of human blood in Triatoma dimidiata captured inside dwellings in a rural community in the Yucatan Peninsula, Mexico, but low antibody seroprevalence and electrocardiographic findings compatible with Chagas disease in humans.

Authors:  Victor Monteon; César Alducin; Jorge Hernández; Angel Ramos-Ligonio; Ruth Lopez
Journal:  Am J Trop Med Hyg       Date:  2013-01-07       Impact factor: 2.345

3.  Revisiting the Homoploid Hybrid Speciation Process of the Triatoma brasiliensis macromelasoma Galvão, 1956 (Hemiptera, Triatominae) Using Cytogenetic and Molecular Markers.

Authors:  Ana Letícia Guerra; Kelly Cristine Borsatto; Nicolle Pagliusi Damiano Teixeira; Fernanda Fernandez Madeira; Jader de Oliveira; João Aristeu da Rosa; Maria Tercília Vilela Azeredo-Oliveira; Kaio Cesar Chaboli Alevi
Journal:  Am J Trop Med Hyg       Date:  2019-04       Impact factor: 2.345

Review 4.  Genetics and evolution of triatomines: from phylogeny to vector control.

Authors:  S Gourbière; P Dorn; F Tripet; E Dumonteil
Journal:  Heredity (Edinb)       Date:  2011-09-07       Impact factor: 3.821

5.  Molecular evidence of intraspecific variability in different habitat-related populations of Triatoma dimidiata (Hemiptera: Reduviidae) from Costa Rica.

Authors:  Melissa Blandón-Naranjo; María Angeles Zuriaga; Gabriela Azofeifa; Rodrigo Zeledón; María Dolores Bargues
Journal:  Parasitol Res       Date:  2010-02-18       Impact factor: 2.289

6.  Reproductive isolation revealed in preliminary crossbreeding experiments using field collected Triatoma dimidiata (Hemiptera: Reduviidae) from three ITS-2 defined groups.

Authors:  Mauricio García; Marianela Menes; Patricia L Dorn; Carlota Monroy; Bethany Richards; Francisco Panzera; Dulce María Bustamante
Journal:  Acta Trop       Date:  2013-09-13       Impact factor: 3.112

7.  Migration and Gene Flow Among Domestic Populations of the Chagas Insect Vector Triatoma dimidiata (Hemiptera: Reduviidae) Detected by Microsatellite Loci.

Authors:  Lori Stevens; M Carlota Monroy; Antonieta Guadalupe Rodas; Robin M Hicks; David E Lucero; Leslie A Lyons; Patricia L Dorn
Journal:  J Med Entomol       Date:  2015-03-12       Impact factor: 2.278

8.  Eco-geographical differentiation among Colombian populations of the Chagas disease vector Triatoma dimidiata (Hemiptera: Reduviidae).

Authors:  Andrés Gómez-Palacio; Omar Triana; Nicolás Jaramillo-O; Ellen M Dotson; Paula L Marcet
Journal:  Infect Genet Evol       Date:  2013-09-11       Impact factor: 3.342

9.  Phylogeographic pattern and extensive mitochondrial DNA divergence disclose a species complex within the Chagas disease vector Triatoma dimidiata.

Authors:  Fernando A Monteiro; Tatiana Peretolchina; Cristiano Lazoski; Kecia Harris; Ellen M Dotson; Fernando Abad-Franch; Elsa Tamayo; Pamela M Pennington; Carlota Monroy; Celia Cordon-Rosales; Paz Maria Salazar-Schettino; Andrés Gómez-Palacio; Mario J Grijalva; Charles B Beard; Paula L Marcet
Journal:  PLoS One       Date:  2013-08-05       Impact factor: 3.240

10.  Unlocking holocentric chromosomes: new perspectives from comparative and functional genomics?

Authors:  Mauro Mandrioli; Gian Carlo Manicardi
Journal:  Curr Genomics       Date:  2012-08       Impact factor: 2.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.